carvedilol has been researched along with Sarcoma, Ewing in 1 studies
Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duckett, MM | 1 |
| Phung, SK | 1 |
| Nguyen, L | 1 |
| Khammanivong, A | 1 |
| Dickerson, E | 1 |
| Dusenbery, K | 1 |
| Lawrence, J | 1 |
1 other study available for carvedilol and Sarcoma, Ewing
| Article | Year |
|---|---|
The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells.
Topics: Adrenergic beta-Antagonists; Animals; Bone Neoplasms; Carvedilol; Cell Line, Tumor; Dog Diseases; Do | 2020 |